ArticleCancers2022

Modified Albumin-Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy.

Wei-Fan Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.